Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4534)
All Articles published online
|
Mar 7, 2013 (publication date) through Dec 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Carrera E, Manzano R, Garrido E. Efficacy of the vaccination in inflammatory bowel disease. World J Gastroenterol 2013; 19(9): 1349-1353 [PMID: 23538553 DOI: 10.3748/wjg.v19.i9.1349] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i9/1349.htm |
| Number | Citing Articles |
| 1 |
Maria de Lourdes Setsuko Ayrizono, Priscilla de Sene Portel Oliveira, João José Fagundes. Biological Therapy for Inflammatory Bowel Disease. 2020; doi: 10.5772/intechopen.90001
|
| 2 |
Cem Cekic, Fatih Aslan, Adnan Kirci, Zeynep Zehra Gümüs, Mahmut Arabul, Elif Sartas Yüksel, Sezgin Vatansever, Süreyya Gül Yurtsever, Emrah Alper, Belks Ünsal. Evaluation of Factors Associated With Response to Hepatitis B Vaccination in Patients With Inflammatory Bowel Disease. Medicine 2015; 94(22): e940 doi: 10.1097/MD.0000000000000940
|
| 3 |
Chang Kyun Lee. Ideal Vaccination Strategy in Inflammatory Bowel Disease. The Korean Journal of Gastroenterology 2015; 65(3): 159 doi: 10.4166/kjg.2015.65.3.159
|
| 4 |
Karin Lye auf der STRASSE, Carmen Mayanna JAMUR, Janaina MARQUES, Mirian Su Mi KIM, Ricardo Rasmussen PETTERLE, Heda Maria Barska dos Santos AMARANTE. IMMUNIZATION STATUS OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE. Arquivos de Gastroenterologia 2019; 56(2): 124 doi: 10.1590/s0004-2803.201900000-26
|
| 5 |
Frank Rouby, Farid Kheloufi, Joëlle Micallef. Third nerve palsy after influenza vaccination in inflammatory bowel disease (IBD). Therapies 2017; 72(6): 695 doi: 10.1016/j.therap.2017.04.005
|
| 6 |
Adérson Omar Mourão Cintra Damião. A guide to prepare patients with inflammatory bowel diseases for anti-TNF-α therapy. Medical Science Monitor 2014; 20: 487 doi: 10.12659/MSM.890331
|
| 7 |
Charlie Wang, Marius Rademaker, Bruce Tate, Christopher Baker, Peter Foley. SARS‐CoV‐2 (COVID‐19) vaccination in dermatology patients on immunomodulatory and biologic agents: Recommendations from the Australasian Medical Dermatology Group. Australasian Journal of Dermatology 2021; 62(2): 151 doi: 10.1111/ajd.13593
|
| 8 |
Samantha Zullow, Francis A. Farraye. Updates on vaccinating the inflammatory bowel disease patient. Expert Review of Gastroenterology & Hepatology 2019; 13(3): 229 doi: 10.1080/17474124.2019.1565993
|
| 9 |
Martha M Eibl, Hermann M Wolf. Vaccination in Patients with Primary Immune Deficiency, Secondary Immune Deficiency and Autoimmunity with Immune Regulatory Abnormalities. Immunotherapy 2015; 7(12): 1273 doi: 10.2217/IMT.15.74
|
| 10 |
Athanasios P Desalermos, Francis A Farraye, Sharmeel K Wasan. Vaccinating the inflammatory bowel disease patient. Expert Review of Gastroenterology & Hepatology 2015; 9(1): 91 doi: 10.1586/17474124.2014.934672
|
| 11 |
Giovanni Mazzola, Fabio Salvatore Macaluso, Lucia Adamoli, Sara Renna, Antonio Cascio, Ambrogio Orlando. Diagnostic and vaccine strategies to prevent infections in patients with inflammatory bowel disease. Journal of Infection 2017; 74(5): 433 doi: 10.1016/j.jinf.2017.02.009
|
| 12 |
Yi Chu, Ming Zuo Jiang, Bing Xu, Wei Jie Wang, Di Chen, Xiao Wei Li, Yu Jie Zhang, Jie Liang. Specific changes of enteric mycobiota and virome in inflammatory bowel disease. Journal of Digestive Diseases 2018; 19(1): 2 doi: 10.1111/1751-2980.12570
|
| 13 |
Amit Herling, Tal Moshe Perluk, Ophir Freund, Nitsan Maharshak, Nathaniel Aviv Cohen. Pulmonary Manifestations of IBD: Case Report and Review of the Literature. Journal of Clinical Medicine 2024; 13(18): 5401 doi: 10.3390/jcm13185401
|
| 14 |
Elda Righi, Tolinda Gallo, Anna Maria Azzini, Fulvia Mazzaferri, Maddalena Cordioli, Mara Merighi, Evelina Tacconelli. A Review of Vaccinations in Adult Patients with Secondary Immunodeficiency. Infectious Diseases and Therapy 2021; 10(2): 637 doi: 10.1007/s40121-021-00404-y
|
| 15 |
Chang Kyun Lee, Hyun-Soo Kim, Byong Duk Ye, Kang-Moon Lee, You Sun Kim, Sang Youl Rhee, Hyo-Jong Kim, Suk-Kyun Yang, Won Moon, Ja-Seol Koo, Suck-Ho Lee, Geom Seog Seo, Soo Jung Park, Chang Hwan Choi, Sung-Ae Jung, Sung Noh Hong, Jong Pil Im, Eun Soo Kim. Patients with Crohn's disease on anti-tumor necrosis factor therapy are at significant risk of inadequate response to the 23-valent pneumococcal polysaccharide vaccine. Journal of Crohn's and Colitis 2014; 8(5): 384 doi: 10.1016/j.crohns.2013.09.022
|
| 16 |
Anita Bálint, Klaudia Farkas, Pallagi-Kunstár Éva, Gabriella Terhes, Edit Urbán, Mónika SzŰcs, Tibor Nyári, Zsuzsanna Bata, Ferenc Nagy, Zoltán Szepes, Pál Miheller, Katalin LŐrinczy, Péter László Lakatos, Barbara Lovász, Szamosi Tamás, Andrea Kulcsár, Anna Berényi, Dalma TörŐcsik, Tímea Daróczi, Zoltán Saródi, Tibor Wittmann, Tamás Molnár. Antibody and cell-mediated immune response to whole virion and split virion influenza vaccine in patients with inflammatory bowel disease on maintenance immunosuppressive and biological therapy. Scandinavian Journal of Gastroenterology 2015; 50(2): 174 doi: 10.3109/00365521.2014.928902
|
| 17 |
Valerie Laniosz, Julia S. Lehman, Gregory A. Poland, David A. Wetter. Literature‐based immunization recommendations for patients requiring immunosuppressive medications for autoimmune bullous dermatoses. International Journal of Dermatology 2016; 55(6): 599 doi: 10.1111/ijd.13140
|
| 18 |
Cristina García-Serrano, Glòria Mirada, Josep R Marsal, Marta Ortega, Joaquim Sol, Rubén Solano, Eva M Artigues, Pepi Estany. Compliance with the guidelines on recommended immunization schedule in patients with inflammatory bowel disease: implications on public health policies. BMC Public Health 2020; 20(1) doi: 10.1186/s12889-020-08850-y
|
| 19 |
Martina Prelog. Reisen mit Immunsuppression – Fokus Impfungen. Reisemedizin up2date 2024; 1(01): 69 doi: 10.1055/a-2189-8911
|